Vertaling van "patients with stroke and transient ischemic " (Frans → Nederlands) :

Furie KL, Kasner SE, Adams RJ et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
professionals from the American Heart Association/American Stroke Association.

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

Search Date February 2009. [http ...]
Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: anti-thrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

LM etal. Aspirin and clopidogrel compared with clopidogrel alone afterrecent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.
LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with Nortriptyline and paroxetine in patients with ischemic heart disease.
17. Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.

18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and Nortriptyline in depressed patients with ischemic heart disease.
18. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Jr., Pollock BG et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of follow up.

Dunn A. Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrilllation. Evid Based Med 2009; 14:140.
Bespreking van: van Walraven C, Hart RG, Conolly S et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the Atrial Fibrillation Investigators.